EMEA-001904-PIP03-18-M02

Key facts

Active substance
Brincidofovir
Therapeutic area
Infectious diseases
Decision number
P/0180/2022
PIP number
EMEA-001904-PIP03-18-M02
Pharmaceutical form(s)
  • Oral suspension
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of smallpox
Route(s) of administration
Oral use
Contact for public enquiries
Chimerix IRL Limited

E-mail: contact@chimerix.com
Tel. +1 9198061074

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating